Cite
MLA Citation
G. Attard et al.. “2537 Preliminary findings from PLATO: A two-period, phase 4, randomized, double-blind, placebo-controlled study of continued enzalutamide treatment beyond progression in men with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC).” European journal of cancer, vol. 51, n.d., pp. S487–. http://access.bl.uk/ark:/81055/vdc_100030628240.0x000012